Literature DB >> 15970197

Identification and purification of actin from the subpellicular network of Toxoplasma gondii tachyzoites.

Araceli Patrón S1, Mónica Mondragón, Sirenia González, Javier R Ambrosio, Alma L Guerrero B, Ricardo Mondragón.   

Abstract

Toxoplasma gondii infects cells through dynamic events dependent on actin. Although the presence of cortical actin has been widely suggested, visualisation and localisation of actin filaments has not been reported. The subpellicular cytoskeleton network is a recently described structure possibly involved in the dynamic events. Using non-ionic detergent extractions, the cortical cytoskeleton network was enriched and used for the isolation and identification of actin. Actin was detected by Western blots in extracts of cytoskeleton networks, and it was localised by gold staining in the network and in both the apical end and the posterior polar ring. Actin was isolated from subpellicular cytoskeleton extracts by binding to DNase I, and it polymerised in vitro as filaments that were gold-decorated by a monoclonal anti-actin antibody. Filaments bound the subfragment 1 of heavy meromyosin, although with atypical arrangements in comparison with the arrowheads observed in muscle actin filaments. Treatment with cytochalasin D and colchicine altered the structural organisation of the subpellicular network indicating the participation of actin filaments and microtubules in the maintenance of its structure. Actin filaments and microtubules, in the subpellicular network, participate reciprocally in the maintaining of the parasite's shape and the gliding motility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15970197     DOI: 10.1016/j.ijpara.2005.03.016

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  6 in total

1.  A new type of quinoxalinone derivatives affects viability, invasion, and intracellular growth of Toxoplasma gondii tachyzoites in vitro.

Authors:  Norma Rivera Fernández; Mónica Mondragón Castelán; Sirenia González Pozos; Carlos J Ramírez Flores; Ricardo Mondragón González; Carmen T Gómez de León; Kitzia N Castro Elizalde; Yovani Marrero Ponce; Vicente J Arán; Miriam A Martins Alho; Ricardo Mondragón Flores
Journal:  Parasitol Res       Date:  2016-02-18       Impact factor: 2.289

2.  Toxoplasma gondii Hsp20 is a stripe-arranged chaperone-like protein associated with the outer leaflet of the inner membrane complex.

Authors:  Natalia de Miguel; Maryse Lebrun; Aoife Heaslip; Ke Hu; Con J Beckers; Mariana Matrajt; Jean F Dubremetz; Sergio O Angel
Journal:  Biol Cell       Date:  2008-08       Impact factor: 4.458

3.  Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis.

Authors:  Li-Tian Yin; Hai-Xia Hao; Hai-Long Wang; Jian-Hong Zhang; Xiao-Li Meng; Guo-Rong Yin
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

4.  A highly dynamic F-actin network regulates transport and recycling of micronemes in Toxoplasma gondii vacuoles.

Authors:  Javier Periz; Mario Del Rosario; Alexandra McStea; Simon Gras; Colin Loney; Lin Wang; Marisa L Martin-Fernandez; Markus Meissner
Journal:  Nat Commun       Date:  2019-09-13       Impact factor: 14.919

5.  In Vitro Effect of the Synthetic cal14.1a Conotoxin, Derived from Conus californicus, on the Human Parasite Toxoplasma gondii.

Authors:  Marco A De León-Nava; Eunice Romero-Núñez; Angélica Luna-Nophal; Johanna Bernáldez-Sarabia; Liliana N Sánchez-Campos; Alexei F Licea-Navarro; Jorge Morales-Montor; Saé Muñiz-Hernández
Journal:  Mar Drugs       Date:  2016-04-08       Impact factor: 5.118

6.  Apicomplexan F-actin is required for efficient nuclear entry during host cell invasion.

Authors:  Mario Del Rosario; Javier Periz; Georgios Pavlou; Oliver Lyth; Fernanda Latorre-Barragan; Sujaan Das; Gurman S Pall; Johannes Felix Stortz; Leandro Lemgruber; Jamie A Whitelaw; Jake Baum; Isabelle Tardieux; Markus Meissner
Journal:  EMBO Rep       Date:  2019-10-04       Impact factor: 8.807

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.